Our Platform
Leveraging an advanced, proprietary multiplexed system capable of analyzing up to 80,000 human olfactory receptor-odorant interactions simultaneously, our platform maps the biological response of human olfactory receptors to odorant molecules at an unprecedented scale.
Utilizing our proprietary NGS-based method, we can capture and encode these receptor-odorant interactions in unique DNA barcode sequences, generating 4-6 billion data points per run, a dataset far exceeding what has been available in olfactory research.
Our multiplexed barcoded platform can map any protein-protein, antibody-antigen and protein-small molecule interactions with unmatched precision, ensuring minimal off-target binding. With our massive interaction scale potential, we are able to design and generate massive high quality lab data.
ORome
ORome is our advanced Olfactory Receptor (OR)-odorant screening engine, designed to decode the complex interactions between olfactory receptors and odorant molecules at unprecedented scale.
Through high-throughput multiplexed screening, ORome generates comprehensive datasets that map receptor responses to diverse odorants, uncovering fundamental principles of olfactory biology. This platform enables researchers to explore the molecular underpinnings of scent perception and opens new pathways for applications in areas like diagnostics, environmental monitoring, and biological interaction studies. ORome aims to bridge gaps in olfactory science, providing a robust foundation for mapping and understanding the sensory world on a molecular level.
Yome
Yome is our antibody-antigen discovery engine, designed to revolutionize the search for therapeutic antibodies across the full spectrum of human biology. With a vision to make it feasible to discover antibodies ultimately for the 800,000+ viruses with zoonotic potential—Yome addresses the urgent need for versatile and rapid antibody solutions. Utilizing a proprietary multiplexed NGS platform, Yome screens tens of thousands of antigens in a single reaction, generating deep datasets that connect antibody sequences to functional outcomes. This powerful capability paves the way for breakthroughs in treating complex diseases and emerging infectious threats, enabling faster, more adaptable solutions for global health.